Bristol Myers to Acquire the Drugmaker Karuna for $14 Billion

The deal is a bet on the growing market for psychiatric and neurological drugs.

Lauren Hirsch
Author: Lauren Hirsch

Comments

Leave a Reply

Your email address will not be published. Required fields are marked *